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Abstract
Background: A variant of the CDKAL1 gene was reported to be associated with type 2 diabetes and reduced insulin release
in humans; however, the role of CDKAL1 in b cells is largely unknown. Therefore, to determine the role of CDKAL1 in insulin
release from b cells, we studied insulin release profiles in CDKAL1 gene knockout (CDKAL1 KO) mice.
Principal Findings: Total internal reflection fluorescence imaging of CDKAL1 KO b cells showed that the number of fusion
events during first-phase insulin release was reduced. However, there was no significant difference in the number of fusion
events during second-phase release or high K
+-induced release between WT and KO cells. CDKAL1 deletion resulted in a
delayed and slow increase in cytosolic free Ca
2+ concentration during high glucose stimulation. Patch-clamp experiments
revealed that the responsiveness of ATP-sensitive K
+ (KATP) channels to glucose was blunted in KO cells. In addition, glucose-
induced ATP generation was impaired. Although CDKAL1 is homologous to cyclin-dependent kinase 5 (CDK5) regulatory
subunit-associated protein 1, there was no difference in the kinase activity of CDK5 between WT and CDKAL1 KO islets.
Conclusions/Significance: We provide the first report describing the function of CDKAL1 in b cells. Our results indicate that
CDKAL1 controls first-phase insulin exocytosis in b cells by facilitating ATP generation, KATP channel responsiveness and the
subsequent activity of Ca
2+ channels through pathways other than CDK5-mediated regulation.
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Introduction
Type 2 diabetes is a multifactorial disease characterized by
decreased insulin secretion and decreased insulin action at target
tissues. While the primary molecular defects in type 2 diabetes
remain largely unknown, genetic factors in combination with
environmental factors are thought to be involved in the onset and
development of the disease. Recent genome-wide association
studies have identified CDKAL1 (cyclin-dependent kinase 5
regulatory subunit associated protein 1-like 1) as a susceptibility
gene for type 2 diabetes, which has been replicated in several
populations [1–5]. The CDKAL1 gene is located on chromosome
6p22.3 and encodes a 65-kDa protein (CDKAL1). The expression
of CDKAL1 mRNA has been detected in human tissues including
pancreatic islets, skeletal muscle and brain [1,4]. Although the
function of CDKAL1 is still unclear, CDKAL1 is similar to cyclin-
dependent kinase 5 regulatory subunit-associated protein 1
(CDK5RAP1), which is expressed in neuronal tissues, and inhibits
cyclin-dependent kinase 5 (CDK5) activity by binding to the
CDK5 activator p35 [6]. CDK5 was previously implicated in islet
function [7–9], suggesting that CDKAL1 plays a role in b cell
function by inhibiting CDK5 kinase activity [1–4].
Genome-wide association studies have shown that several
single-nucleotide polymorphisms (SNPs) in intron 5 of the
CDKAL1 gene are associated with type 2 diabetes [1–4]. An
association between SNPs and insulin release has also been
suggested [2,3]. Recently, Groenewoud et al. [10] and Stancakova
et al. [11] reported that a CDKAL1 variant (rs7754840) decreased
first-phase insulin secretion but not second-phase insulin secretion
during hyperglycemic clamps and intravenous glucose tolerance
tests, respectively. Furthermore, the gene variants were not
associated with the insulin sensitivity index [10,11], suggesting
that CDKAL1 variants influence the risk of type 2 diabetes by
impairing first-phase insulin secretion. However, the molecular
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15553mechanisms through which CDKAL1 modulates insulin release in
pancreatic b cells are unknown.
To understand the role of CDKAL1 in b cells, we studied the
phenotype of mice deficient in CDKAL1 expression, which was
established using a gene-trap technique (CDKAL1 KO mice). Our
data demonstrate that CDKAL1 has a role in first-phase insulin
exocytosis in b cells by facilitating ATP generation, KATP channel
responsiveness and subsequent Ca
2+ channel activity; surprisingly,
these effects were independent of CDK5 activity.
Results
Expression and histological examination of CDKAL1 KO
mice
To explore the potential role of CDKAL1 in b cells, we studied
CDKAL1 KO b cells. CDKAL1 KO mice did not express CDKAL1
mRNA in pancreatic islets or the brain (Fig. 1A). In immunoblot
analysis (Fig. 1B), CDKAL1 protein was not detected in KO islets
or KO brain, whereas it was more highly expressed in WT islets
than in WT brain. We next morphologically examined the
pancreatic islets. Immunostaining of pancreatic sections with
insulin antibodies revealed no significant difference in islet
architecture, including b cell area per pancreas, between WT
and KO mice (Fig. 2A–B). Electron microscopy of the pancreatic
b cells also revealed that cell size, total number of granules per
section and mean granule diameter were similar in WT and KO b
cells (Fig. 2C–F). Furthermore, pancreatic insulin content, islet
DNA content and islet insulin content of CDKAL1 KO mice were
similar to those of WT mice (Fig. 2G–I). Thus, CDKAL1 KO b
cells displayed specific CDKAL1 protein depletion but their
characteristics were similar to those of WT cells.
Effects of CDKAL1 KO on glucose-induced biphasic insulin
exocytosis
We next investigated the effects of CDKAL1 KO on glucose-
induced insulin release from b cells. Batch experiments showed
that 16.7 mM glucose-induced insulin release (for 30 min) from
CDKAL1 KO b cells was decreased (,19%) relative to that from
WT b cells (P=NS) (Fig. 3A). To evaluate in detail the effects of
CDKAL1 deficiency on glucose-evoked biphasic insulin exocyto-
sis, the dynamic motion of individual insulin granules tagged with
green fluorescent protein (GFP) was observed under total internal
reflection fluorescence (TIRF) microscopy. As previously reported
[12], stimulation with 22 mM glucose evoked biphasic insulin
granule exocytosis through fusion of two types of granules
(previously docked granules and newcomers) in WT b cells (Fig.
3B, top). During the first phase (within 5 min), the fusion events
mostly occurred from the previously docked granules with some of
the fusion events from newcomers while continuous fusion was
observed thereafter, mostly from newcomers during the second
phase (over 15 min). In contrast, CDKAL1 KO b cells showed
abnormalities in biphasic insulin granule exocytosis (Fig. 3B,
bottom) because the number of fusion events during the first phase
was significantly reduced in KO cells [WT (n=16) vs. KO
(n=14), 43.066.2 vs. 12.763.8, P,0.001]. In contrast, during the
second phase, the number of fusion events tended to be increased
but there was no significant difference [WT (n=16) vs. KO
(n=14), 87.366.4 vs. 105.668.0, P=NS].
On the other hand, high K
+-induced granule fusion was normal
in KO cells (Fig. 3C), suggesting that the exocytotic steps after the
elevation of intracellular calcium concentration ([Ca
2+]i) were not
impaired in KO cells. In fact, the number of morphologically
docked insulin granules observed by TIRF and electron
microscopy (Fig. 4A and B), and fusion kinetics (data not shown)
were not altered in CDKAL1 KO b cells. In addition, the
expression levels of SNARE proteins (syntaxin1A, SNAP25 and
VAMP2), important mediators of insulin granule docking and
fusion [12], were similar in WT and KO b cells (Fig. 4C). These
results indicate that granule docking and Ca
2+-triggered fusion are
not impaired in CDKAL1 KO b cells.
Changes in the [Ca
2+]i increase in KO cells
To determine whether the impairments in glucose-induced first-
phase insulin exocytosis were associated with changes in the
[Ca
2+]i increase, we monitored the time-course of the glucose-
induced [Ca
2+]i increase using Fura-2 methods. CDKAL1 KO
resulted in a delayed and slow increase in [Ca
2+]i during high
glucose stimulation with a similar time-course to insulin exocytosis
in KO cells. In contrast, a rapid and marked [Ca
2+]i rise was
observed in WT cells (Fig. 5A). The mean lag time (D time from
stimulation to onset) and rise time (D time from onset to peak) were
slower in KO cells than in WT cells [WT vs. KO (n=12 each) lag
time: 1.260.1 min vs. 3.060.1 min, P,0.0001; rise time:
3.060.2 min vs. 4.160.2 min, P,0.001]. The magnitude of the
[Ca
2+]i rise was not different between KO and WT cells.
Furthermore, there was no difference in the high K
+-induced
[Ca
2+]i rise between KO and WT cells (Fig. 5B). These data
suggest that specific steps in glucose-induced early signal
transduction that precede the [Ca
2+]i rise were impaired in KO
cells.
The responsiveness of the KATP channel current to
glucose was impaired in CDKAL1 KO b cells
We next investigated the function of KATP channels in CDKAL1
KO cells. As shown in Fig. 6A, there were no differences in the
expression of the KATP channel components Kir6.2 and SUR1
between WT and KO islets. The KATP channel currents evoked
by the voltage ramp from 2100 to 250 mV in WT and KO mice
are expressed as the current density determined as the calculated
conductance (pS) divided by the cell capacitance (pF). The KATP
currents were determined in the presence of 2.8 and 8.3 mM
Figure 1. CDKAL1 expression is absent in CDKAL1 KO mice.
A. RT-PCR analysis of pancreatic islets and the whole brain of WT and
CDKAL1 KO mice. The CDKAL1 transcript was not detected in CDKAL1 KO
mice. B. Immunoblot analysis. Homogenates of mouse pancreatic islets
and whole brain (30 mg) were subjected to SDS-PAGE and immuno-
blotted with anti-CDKAL1 antibody. The protein band below the
CDKAL1 protein (*) is a nonspecific protein band detected by the anti-
CDKAL1 antibody.
doi:10.1371/journal.pone.0015553.g001
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densities at 2.8 mM glucose were 392.96121.6 pS/pF in WT
(n=6) and 639.56145.1 pS/pF in KO cells (n=8) (P.0.05). In
WT cells, the KATP current density decreased significantly by
increasing the glucose concentration from 2.8 to 8.3 mM (Fig. 6D;
P,0.02), while there was a relatively small, non-significant
decrease in the current density in KO mice (Fig. 6E; P.0.05).
In addition, the time to the most inhibited level of KATP currents
after exposing b cells to 8.3 mM glucose tended to be longer in
KO cells (4.7361.16 min, n=5) compared with that in WT cells
(3.1160.48 min, n=6; P.0.05). Thus our data indicate that the
KATP channel responsiveness to glucose stimulation was blunted in
CDKAL1 KO b cells compared with WT cells.
On the other hand, we did not observe any differences in the
ATP sensitivity of the channel in studies using inside-membrane
patches. The half-maximal concentration of channel inhibition for
ATP was 2.6 mM (n=9) in CDKAL1 KO mice (data not shown),
which is less than those previously reported in control mice
[13,14]. These results suggest that changes in KATP channel
activity in KO cells were not responsible for the reduced ATP
sensitivity of these channels.
ATP generation was impaired in KO cells
It is conceivable that the reduced KATP channel responsiveness to
glucose in KO cells might be due to a defect in ATP production
following glucose metabolism. Therefore, we measured ATP
content in islets from WT and KO mice after incubation with 2.2
and 22 mM glucose using high-performance liquid chromatogra-
phy (HPLC) with a reverse-phase column. As shown in Fig. 7A,
ATP content was significantly increased in WT islets by stimulation
Figure 2. Pancreatic histology and insulin content in CDKAL1 KO mice. A. CDKAL1 KO mice have normal islet architecture. Pancreatic sections
were peroxidase stained for insulin. Scale bar: 100 mm. B. Relative area occupied by b cells (percentage of total pancreatic area). Random sections of
the entire pancreas from WT and CDKAL1 KO mice were immunostained (as shown in A) and analyzed (60 sections from each of three mice per
group). C–F. Electron micrographs of pancreatic tissue sections. C Representative sections (scale bar: 5 mm), D b cell size, E total number of granules
per cell section, and F mean granule diameter in ultra-thin sections (100 nm) (n=20 cells per group) of CDKAL1 KO and WT b cells. G–I. Insulin
content in CDKAL1 KO mice. G Pancreatic insulin content measured in acid-ethanol extracts from WT and KO mice by ELISA (n=6 per group). H DNA
content per islet and I islet insulin content per DNA from WT and KO mice (n=6 per group). Results are means6SEM.
doi:10.1371/journal.pone.0015553.g002
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theKO islets showed a small butnotstatisticallysignificant increase,
indicating impaired glucose metabolism in KO islets.
In line with glucose metabolism, we measured changes in the
mitochondrial membrane potential in WT and KO cells during
glucose stimulation using tetramethyl rhodamine ethyl ester
Figure 3. Effects of CDKAL1 KO on glucose-induced biphasic insulin exocytosis. A. Insulin release (for 30 min) in batch-incubated WT and
CDKAL1 KO b cells in the presence of 2.2 mM or 16.7 mM glucose (n=8 per group). B. Histogram showing the number of fusion events from GFP-
tagged granules in wild-type (WT) and CDKAL1 KO b cells (per 200 mm
2) at 1-min intervals after stimulation with 22 mM glucose and measured by
TIRF microscopy. Data are mean6SEM (WT, n=16 cells; KO, n=14 cells). Time 0 indicates the addition of 22 mM glucose. The red column shows
fusion events from previously docked granules, and the green column shows those from newcomers. C. Histogram showing the number of fusion
events in WT and KO b cells (per 200 mm
2) at 1-min intervals after 40 mM high K
+ stimulation measured by TIRF microscopy (n=8 cells per group).
doi:10.1371/journal.pone.0015553.g003
CDKAL1 and Insulin Exocytosis
PLoS ONE | www.plosone.org 4 December 2010 | Volume 5 | Issue 12 | e15553Figure 4. CDKAL1 KO did not affect the number of morphologically docked granules or granule fusion kinetics. A. Total internal
reflection fluorescence (TIRF) microscopy of insulin granules morphologically docked to the plasma membrane. (top) Typical TIRF images of docked
insulin granules in WT and CDKAL1 KO b cells. The surrounding lines represent the outline of cells attached to the cover glass. Scale bar: 5 mm.
Pancreatic b cells were prepared from WT and KO mice, fixed, and immunostained for insulin. (bottom) Number of insulin granules morphologically
docked to the plasma membrane. Individual fluorescent spots shown in the TIRF images were manually counted per 200 mm
2 in 15 cells per group.
B. Electron micrograph of b cell sections. (top) Typical images of the plasma membrane area facing the blood capillary (C) of WT and KO b cells (B).
Bar: 500 nm. (bottom) Number of morphologically docked insulin granules per 10 mm of the plasma membrane. Granules at their shortest distance of
,10 nm from the plasma membrane were defined as morphologically docked granules (red arrowheads). Results are means6SEM. C. Expression of
SNARE proteins in wild-type (WT) and KO islets by immunoblotting. Equal amounts of islet protein (30 mg) were separated by SDS-PAGE and
immunoblotted. b-actin was used as a loading control.
doi:10.1371/journal.pone.0015553.g004
Figure 5. Effects of CDKAL1 KO on changes in intracellular free calcium ([Ca
2+]i). A 22 mM glucose- and B 40 mM high K
+-induced changes
in [Ca
2+]i in WT and CDKAL1 KO b cells. Changes in [Ca
2+]i were measured by Fura-2 acetoxymethyl (2 mM). Time 0 indicates when the stimulants were
added. The fluorescence ratio (340/360) at time 0 was taken as 1. Results are means6SEM (n=12 cells per group).
doi:10.1371/journal.pone.0015553.g005
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potential is evident by an increase in the fluorescent intensity of
TMRE [15]. CDKAL1 KO cells exhibited a significantly reduced
membrane potential response to glucose stimulation compared
with WT cells (Fig. 7B). The reduced mitochondrial membrane
potential response was further confirmed using a-ketoisocaproate
(KIC) (Fig. 7C), which is a direct substrate for the mitochondrial
TCA cycle and bypasses glycolysis [16]. Thus, it seems reasonable
to conclude that the defective ATP generation in KO cells is due
to impaired mitochondrial function, without changes in mito-
chondrial number or morphology in KO cells on electron
microscopy (data not shown).
CDK5/p35 protein kinase activity in CDKAL1 KO islets
CDKAL1 is homologous to CDK5RAP1, which inhibits CDK5
activity by binding to the kinase activator p35 [6]. To test whether
CDK5-mediated regulation is involved in the function of
CDKAL1 in b cells, we examined the expression and protein
kinase activity of CDK5 in CDKAL1 KO islets. CDK5 and p35
were expressed in KO islets as much as in WT islets (Fig. 8A).
Surprisingly, we found no difference in CDK5/p35 kinase activity
between CDKAL1 KO and WT islets, when using histone H1 as a
substrate after immunoprecipitation with a p35-specific antibody
(Fig. 8B). The specificity of this activity was confirmed using the
CDK5 inhibitor roscovitine. Thus, it seems likely that CDK5
kinase does not contribute to CDKAL1 function in b cells.
Subcellular localization of CDKAL1 in b cells
Finally, we examined the subcellular localization of CDKAL1
using a biochemical subcellular fractionation of MIN6 b cells. In
the fractionation procedure [17], the postnuclear S1 fraction was
separated by differential centrifugation into an S2 soluble
cytosolic/microsomal fraction and a pellet membrane fraction.
Then, the S2 fraction was separated into the S3 soluble cytosolic
fraction. Endogenous proteins were used as markers for cytosolic
(MEK-1/2), endoplasmic reticulum (ER) (BIP/GRP78), mito-
chondrial (Bcl2), and plasma membrane proteins (SNAP25).
CDKAL1 immunoreactivities were detected in the S2 and pellet
fractions, but not in the S3 soluble cytosolic fraction (Fig. 9A),
suggesting that CDKAL1 seems to associate with microsomes or
plasma membrane.
We next performed immunocytochemistry to confirm the
subcellular localization of CDKAL1 in b cells. The CDKAL1
antibody cross-reacted with a non-specific protein band (Fig. 1B
Figure 6. Effects of the increase in glucose concentration on KATP channel currents in WT and CDKAL1 KO b-cells. A. Expression of Kir6.2
and SUR1 proteins in WT and KO islets by immunoblotting. Equal amounts of islet protein (30 mg) were separated by SDS-PAGE and immunoblotted.
b-actin was used as a loading control. B–E.K ATP-channel currents expressed as current density in the ramp-clamp mode between 2100 mV and
250 mV at a rate of 0.5 mV/ms in the presence of 2.8 mM (red line) or 8.3 mM glucose (black line) in WT (B and D) and KO b cells (C and E). Dotted
lines indicate 0 A. Results are means6SEM and paired t-test was used to compare the data.
doi:10.1371/journal.pone.0015553.g006
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immunostaining. In fact, in immunostaining experiments with the
CDKAL1 antibody, we could not detect any specific signal in WT
cells (data not shown). Therefore, we expressed the CDKAL1
protein as a fusion with enhanced green fluorescent protein
(EGFP) and the intracellular localization was examined under a
confocal microscope immunostaining with organelle markers or
with MitoTracker staining. As shown in Fig. 9B, the fluorescence
of the CDKAL1–EGFP protein was colocalized with the ER
protein calnexin, but not with MitoTracker Red (a mitochondria
marker). These results suggest that CDKAL1 is predominantly
localized to the ER.
Discussion
In this study, we found that pancreatic b cells from mice null for
CDKAL1, which was identified as a susceptibility gene for type 2
diabetes in humans, have a reduced first-phase insulin release in
vitro. TIRF imaging revealed that CDKAL1 KO caused a marked
reduction in the number of fusion events during first-phase release
(Fig. 3), but not in second-phase release. The impaired glucose-
induced first-phase insulin exocytosis was associated with a delayed
and slow increase in [Ca
2+]i during glucose stimulation in KO cells
(Fig. 5). This may be due to the blunted responsiveness of KATP
channels to glucose stimulation in KO cells (Fig. 6). Indeed, ATP
production in KO cells was low (Fig. 7) and may lead to blunted
glucose-induced KATP channel responsiveness followed by im-
paired Ca
2+ channel activity.
The target molecules for CDKAL1 are not yet known, although
our data indicate that CDKAL1 KO influences glucose-induced
KATP channel responsiveness through reduced ATP generation.
Since CDKAL1 is similar to CDK5RAP1, we originally
speculated that the function of CDKAL1 is mediated by CDK5,
and is probably directly associated with increased Ca
2+ channel
activity, as observed in p35 KO mice [8], or with insulin gene
expression [7,9]. However, there was no relationship between
CDKAL1 and CDK5 in this study. Therefore, CDK5/p35-
mediated regulation does not seem to be involved in CDKAL1
regulation of insulin release. Our data suggest that CDKAL1 is
instead related to glucose metabolism, which is associated with
ATP generation, KATP channel activity and Ca
2+ channels
activity.
The failure of glucose-induced ATP-generation may be due to
defects at several stages of glucose metabolism including cytosolic
glycolysis and mitochondrial metabolism. In CDKAL1 KO cells,
the glucose-stimulated mitochondrial membrane potential re-
sponse was blunted (Fig. 7B). In addition, KIC, which is a direct
substrate for the TCA cycle, bypassing glycolysis, also reduced the
mitochondrial membrane potential response (Fig. 7C). Therefore,
blunted mitochondrial membrane potential response is likely to be
a key defect, resulting in a reduced ATP generation, KATP channel
responsiveness and Ca
2+ channel activity, and eventually leading
to impaired insulin granule exocytosis in KO cells. Indeed, it has
Figure 7. Effects of CDKAL1 KO on ATP generation. A. ATP
content in WT and CDKAL1 KO islets. HPLC was used to measure ATP
content in islets from WT and KO mice after incubation with 2 or 22 mM
glucose. Results are means6SEM (n=7 per group). B, C. Changes in
mitochondrial membrane potential in response to 22 mM glucose (B)
and 10 mM KIC (C) in WT and KO b cells. Changes in mitochondrial
membrane potential were measured by a mitochondrial potential
sensitive dye TMRE (10 nM). Time 0 indicates when the stimulants were
added. The fluorescence intensity at time 0 was taken as 100%. Results
are means6SEM (n=12 cells per group).
doi:10.1371/journal.pone.0015553.g007
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insulin release in diabetic Goto-Kakizaki rats is associated with
reduced sensitivity of KATP channels to glucose by deficient
oxidative metabolism of glucose in mitochondria [18,19].
In KO cells, cytosolic free [Ca
2+]i induced by glucose gradually
reached the same level observed in WT cells. We assume that the
increase of [Ca
2+]i during second-phase may reflect suppression of
Ca
2+ clearance mechanism. As for other animal cells, four
mechanisms remove Ca
2+ from cytosol of b cells: sarco-
endoplasmic reticulum Ca
2+-ATPase (SERCA) pumps, plasma
membrane Ca
2+-ATPase (PMCA), Na
+/Ca
2+ exchanger (NCX),
and the calcium uniporter of mitochondria [20,21]. In mouse and
rat b cells, the SERCA pump is the dominant Ca
2+ clearance
mechanism [20,21], thus it is conceivable that reduced ATP
generation impairs the Ca
2+ clearance function via the SERCA
pump, resulting that there is no difference of [Ca
2+]i in second-
phase between KO and WT cells.
As shown in Fig. 9, CDKAL1 is likely to localize to the ER in b
cells. The relationship between CDKAL1 deletion in the ER and
reduced mitochondrial ATP generation remains unknown.
However, it has been reported that the ER and mitochondria
are in close contact, which supports communication between these
two organelles [22]. It is possible that ER dysfunction caused by
CDKAL1 KO may affect mitochondrial function in the KO cells.
Such ER–mitochondria communication has been shown to
involve the ER stress pathway [22,23], even in b cells [24,25].
Very recently, Arragain et al. reported that CDKAL1 is a
methylthiotransferase involved in the biosynthesis of 2-methythio-
N6-threonylcarbamoyladenosine in transfer RNA (tRNA) [26].
The methylthio modification of adenosine in tRNA appears to be
essential for efficient and highly accurate protein translation by the
ER ribosome. However, it is still unclear how the role of CDKAL1
in tRNA may be linked to ER function or ATP generation in
mitochondria. Thus, it is tempting to speculate that either ER
dysfunction or ER stress may affect the mitochondrial membrane
potential in KO cells.
It is particularly interesting to note that our TIRF imaging data
showed that CDKAL1 deletion only impaired the first-phase, but
not the second-phase, of glucose-induced insulin exocytosis. Our
data are in good agreement with the results of Groenewoud et al.
[10] and Stancakova et al. [11], who reported that CDKAL1
variants decreased first-phase insulin secretion but not second-
phase insulin in humans with type 2 diabetes. Thus, the altered
expression of CDKAL1 is probably associated with reduced
Figure 8. CDK5/p35 protein kinase activity in CDKAL1 KO islets. A. Detection of CDK5 and p35 proteins in WT and KO islets by
immunoblotting. Equal amounts of islet protein (20 mg) were separated by SDS-PAGE and immunoblotted. b-actin was used as a loading control.
B. Detection of CDK5/p35 kinase activity in WT (lanes 1–3) and KO (lanes 4–6) islets. After immunoprecipitation with a p35-specific antibody in WT
and KO islets, kinase activity was measured using histone H1 as the substrate in the presence (+) or absence (2) of a CDK5 inhibitor roscovitine (Ros;
20 mM). Quantification is shown in the lower panel as means6SEM (n=3 per group).
doi:10.1371/journal.pone.0015553.g008
Figure 9. Subcellular localization of CDKAL1 in b cells.
A. Subcellular fractionation for CDKAL1 localization. The postnuclear
fraction (S1) from MIN6 b cells homogenates was fractionated by
differential centrifugation (see Methods). Equal amounts (2 mg protein)
of the fractions obtained were analyzed by immunoblotting with the
indicated antibodies. S2, soluble cytosolic/microsomal fraction; Pellet,
membrane fraction; S3, soluble cytosolic fraction. The protein band
below the CDKAL1 protein (*) is a nonspecific protein band detected by
the anti-CDKAL1 antibody. B. Immunocytochemical localization of
CDKAL1 in MIN6 b cells. MIN6 b cells were transfected with EGFP–
CDKAL1 and intracellular localization was examined using a confocal
microscope with MitoTracker Red staining or immunostaining with anti-
calnexin IgG (ER marker), as indicated.
doi:10.1371/journal.pone.0015553.g009
CDKAL1 and Insulin Exocytosis
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increased risk for diabetes.
Although our data showed a critical role of CDKAL1 in insulin
exocytosis in vitro, the CDKAL1 KO mice had almost normal
glucose homeostasis (N. Kato, in submission). The reason for the
normal glucose homeostasis in vivo, despite reduced first-phase
insulin release in vitro, is unknown, but there are several
possibilities to be considered. First, the magnitude of the reduction
in first-phase insulin release is not sufficient to cause impaired
glucose tolerance in mice at this stage we examined. In fact,
Stancakova et al. [11] reported that the SNP rs7754840 of
CDKAL1 is associated with impaired insulin secretion in non-
diabetic offspring of type 2 diabetic subjects and in a large sample
of men with normal glucose tolerance. Second, the role of
CDKAL1 on the regulation of insulin exocytosis may have a
limited influence on whole-body glucose metabolism. Therefore,
additional genetic and environmental factors may be needed to
cause impaired glucose tolerance.
In summary, we have provided the first report documenting a
role of CDKAL1 in b cells. Our study using CDKAL1 KO mice
shows that CDKAL1 controls first-phase insulin exocytosis in b
cells by facilitating ATP generation, glucose-induced KATP
channel responsiveness and subsequent Ca
2+ channel activity.
Defects in this process caused by decreased CDKAL1 expression
levels may confer an increased risk of diabetes.
Methods
Generation of CDKAL1 KO mice
CDKAL1 KO mice were generated by the gene-trapping method
[27–29] at TransGenic Inc. (Kobe, Japan) and thereafter
established as an experimental model at the National Center for
Global Health and Medicine. Male mice were used at the age of
10–14 weeks. Animal experiments were approved by the Animal
Care and Use Committee of NCGM Research Institute (permit
number: 22-TG-35) and the Kyorin University Animal Care
Committee (permit number: 65-2).
Islets and pancreatic b cells
Pancreatic islets of Langerhans were isolated from male WT
and CDKAL1 KO mice by collagenase digestion, as previously
described [30]. The isolated islets were then dispersed and
cultured [30]. To label the insulin secretory granules, pancreatic
b cells were infected with recombinant adenovirus Adex1CA
insulin–GFP [30].
RT-PCR
Total RNA was extracted using an Illusta kit (GE healthcare,
Piscataway, NJ, USA), and the full-length CDKAL1 was amplified
by RT-PCR using specific primers (forward primer: ctctcagttcg-
gacagattcatctttcaagaggac; reverse primer: gctgtgatctggtctgaggtca-
gatggc; product 2 kb). The PCR product was separated on agarose
gels.
Immunoblotting
Proteins were extracted from mouse pancreatic islets and whole
brain and immunoblotted [12,31]. We used antibodies targeting
the following proteins: CDKAL1 (ab68045, Abcam, Cambridge,
UK), p35 (C19, Santa Cruz, CA, USA), CDK5 (DC17, Santa
Cruz), syntaxin 1A (a gift from Dr. T. Fujiwara, Kyorin University
School of Medicine, Tokyo, Japan), SNAP25 (Wako Pure
Chemical Industries Ltd., Osaka, Japan), VAMP2 (StressGen
Biotechnologies Corp, Victoria, BC, Canada), Kir6.2 (Santa
Cruz), SUR1 (Santa Cruz), MEK-1/2 (Cell Signaling Technology,
Beverly, MA, USA), BIP/GPR78 (BD Transduction Laboratories,
Lexington, KY, USA), Bcl-2 (BD Transduction Laboratories) and
b-actin (Sigma-Aldrich, St. Louis, MO, USA).
Morphometric analysis of islets
To analyze islet size and b cell mass, paraffin-embedded
pancreas sections (10 mm) were labeled with anti-insulin antibodies
and detected by an avidin-biotin-peroxidase technique (Vector
Laboratories, Burlingame, CA, USA). Sections were collected at
500 mm intervals from tissue blocks, and all islets in the sections
were analyzed to determine islet area as a percentage of total
pancreatic area. Images were acquired with an Olympus
microscope IX70 equipped with a charge-coupled device camera,
and analyzed with Metamorph software (Molecular Devices,
Downingtown, PA, USA).
Electron microscopy
Electron microscopy was carried out using previously described
methods [12]. Tissues were fixed in phosphate-buffered 2.5%
glutaraldehyde (pH 7.4), postosmicated, dehydrated with graded
alcohols, and embedded in Epon 812. After staining with uranyl
acetate and lead citrate, ultra-thin sections were examined under a
transmission electron microscope (TEM-1010C, JEOL, Akishima,
Tokyo, Japan). In electron microscopy, granules at their shortest
distance of ,10 nm from the plasma membrane were defined as
morphologically docked granules.
Insulin content
To measure insulin content in the whole pancreas, the excised
pancreata were frozen in liquid nitrogen and disrupted with
Cryopress (Microtech Nichion, Funabashi, Japan). The resulting
powder was then suspended in cold acid-ethanol, and insulin was
extracted overnight at 4uC [32]. The supernatants were diluted
and subjected to enzyme-linked immunosorbent assays (ELISA) as
described previously [12]. Insulin content per isolated islet was
measured by ELISA [12]. Hoechst-33258 staining of sonicated
islets was performed to determine the islet DNA content.
Insulin release in batch incubated b cells
Batch incubation experiments for insulin release have been
described elsewhere [33]. Briefly, after plating WT and KO cells
on 96-well plates, the cells were preincubated for 30 min in Krebs-
Ringer buffer (KRB) containing (in mM): 110 NaCl, 4.4 KCl, 1.45
KH2PO4, 1.2 MgSO4, 2.3 calcium gluconate, 4.8 NaHCO3, 2.2
glucose, 10 HEPES, pH 7.4, and 0.3% bovine serum albumin
(BSA), and then challenged with 2.2 mM glucose or 22 mM
glucose for 30 min. At the end of the stimulation period, the cells
were disrupted by sonication and aliquots of media and cell
extracts were analyzed by ELISA. The released insulin is
expressed as a percentage of total cellular content.
TIRF microscopy
The Olympus total internal reflection system with a high-
aperture objective lens was used as described previously [12].
Briefly, primary b cells expressing insulin–GFP on the glass cover
slip (Olympus, Tokyo, Japan) were mounted in an open chamber
and incubated for 30 min with KRB. Cells were then transferred
to a thermostat-controlled stage (37uC) and stimulated with
22 mM glucose (final) and 40 mM KCl (final). To evaluate the
number of docked insulin granules by TIRF microscopy, wild-type
and CDKAL1 knockout cells were cultured on high refractive index
glass, fixed, permeabilized with 4% paraformaldehyde/0.1%
Triton X-100, and processed for immunohistochemistry [12].
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processed with goat anti-mouse IgG conjugated to Alexa Fluor-
488 (Molecular probes, Eugene, OR, USA). Immunofluorescence
was detected by TIRF microscopy.
Measurements of intracellular free Ca
2+ ([Ca
2+]i)
Fura-2 acetoxymethyl ester (Fura-2 AM: Molecular Probes) was
loaded into cultured b cells and the ARGUS/HiSCA system
(Hamamatsu photonics, Hamatsu, Japan) was used for measure-
ment, as previously described [12].
Patch-clamp experiments in mouse single b cells
Perforated whole-cell currents were recorded using a pipette
solution containing amphotericin B (200 mg/ml) dissolved in 0.1%
DMSO [34]. Membrane currents were recorded using an
amplifier (200B; Axopatch, Foster, CA) and stored online in a
computer running pCLAMP10.2 software. The voltage clamp in
perforated mode was considered to be adequate when the series
resistance was ,20 MV. Patch pipettes were pulled from glass
tubes (Narishige, Tokyo, Japan); the resistances of the pipettes
ranged from 4 to 7 MV when filled with the pipette solution
containing 40 mM K2SO4, 50 mM KCl, 5 mM MgCl2, 0.5 mM
EGTA and 10 mM HEPES at pH 7.2 with KOH. To record the
KATP channel current, the b cells were voltage-clamped to the
holding potential of 270 mV, stepped to 2100 mV to apply the
voltage ramp from 2100 to 250 mV at a speed of 5 mV/100 ms,
and stepped back to 270 mV every 10 s. Electrophysiological
experiments were performed at room temperature (25uC).
Measurement of islet ATP content
The ATP content of pancreatic islets was measured by HPLC
using a modified version of previously described methods [35,36].
Experiments were performed on islets from WT and KO mice after
incubation overnight in RPMI containing 11 mM glucose. Groups of
25 islets were hand-picked and preincubated in KRB containing
2.2 mM glucose for 60 min. After preincubation, the islets were
incubated for 5 min in KRB containing 2.2 or 22 mM glucose.
Then, ATP was extracted with 0.4 M perchloric acid and assayed by
HPLC with a reversed-phase SUPELCOSIL column (LC-18-T,
3 mm, 1564.6 mm, Sigma-Aldrich) according to the manufacturer’s
instructions. ATP levels were standardized to protein concentrations.
Mitochondrial membrane potential
WT and KO cells cultured on cover glass were loaded with
10 nM TMRE (Molecular Probes) [15] for 45 min in KRB
containing 2.2 mM glucose and washed and incubated for a
further 15 min with KRB. We obtained TMRE fluorescence
images from multiple individual cells before and after increasing
the extracellular glucose concentration from 2.2 mM to 22 mM or
with 10 mM KIC (Nakarai Tesque Inc, Kyoto Japan) using
confocal fluorescent microscopy (FV-1000, Olympus) [543-nm
laser line and emission filter set (BA 560–620)].
Immunoprecipitation and detection of the histone H1
kinase activity of CDK5
The kinase activity of CDK5/p35 was measured after
immunoprecipitation with anti-p35 antibody, as previously
described [31]. Briefly, the isolated islets were sonicated in MOPS
buffer (20 mM MOPS, pH 6.8, 1 mM EGTA, 0.1 mM EDTA,
0.3 M NaCl, 1 mM MgCl2, 0.5% Nonidet P-40, 0.2 mM Pefabloc
SC, 1 mg/ml leupeptin, and 1 mM DTT), and centrifuged at
20,0006g for 30 min to collect the supernatant. The kinase
activity of CDK5-p35 immunoprecipitated with anti-p35 antibody
(C19, Santa Cruz) from an equal protein amount of islet extract
was measured using histone H1 as a substrate in the absence or
presence of 20 mM roscovitine.
Subcellular localization of CDKAL1 in b cells
Fractionation by differential centrifugation was performed with
minor modification as described previously [17]. MIN6 b cells (a
gift from Dr. J.-I. Miyazaki, Osaka University, Osaka, Japan) were
homogenized in sucrose buffer (5 mM HEPES (pH 7.5), 0.32 M
sucrose, and protease inhibitors). The homogenates were centri-
fuged at 8006g for 10 min to obtain the postnuclear supernatant
(S1). S1 was centrifuged at 8,9006g for 15 min to separate the S2
soluble cytosolic/microsomal fraction and precipitate. The
precipitate was resuspended in sucrose buffer, and centrifuged at
540,0006g for 2 h, to yield the pellet (membrane fraction). The S2
fraction was centrifuged for 1 h at 540,0006g for 2 h, yielding a
soluble cytosolic fraction (S3). Equal amounts (2 mg protein) of the
fractions were separated by SDS-PAGE and immunoblotted with
specific antibodies.
EGFP–CDKAL1 was generated using a cDNA fragment
encoding a full open reading frame of murine CDKAL1 (Dnaform,
Kanagawa, Japan), N-terminally tagged with EGFP, and subcloned
into the HindIII/KpnI site of a pcDNA3 vector (Invitrogen). For
immunohistochemical localization of CDKAL1, MIN6 b cells were
transfected with EGFP–CDKAL1 using Lipofectamine2000 (In-
vitrogen) according to the manufacturer’s instructions and cultured
for 2 days. The intracellular localization was examined under a
confocal microscope with MitoTracker (Red CM-H2XRos,
Molecular probes) staining (100 nM for 20 min) or immunostaining
(fixed and permeabilized with 4% paraformaldehyde/0.1% Triton
X-100) with anti-calnexin antibody.
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